Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Abstinence does not reduce HCC risk in alcoholic-related cirrhosis
PARIS — Alcohol abstinence did not reduce the risk for hepatocellular carcinoma among patients with Child-Pugh class A or B alcohol-related cirrhosis, according to a presentation at the International Liver Congress 2018.
Male BRCA carriers at risk for melanoma, pancreatic cancer
It may be appropriate to screen for melanoma and pancreatic cancer in addition to prostate and breast cancer among men carrying BRCA mutations, according to a research letter published in JAMA Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
Shorter adjuvant chemotherapy duration may be sufficient for stage III colon cancer
DFS following 3 months of adjuvant chemotherapy for stage III colon cancer appeared equivalent to 6 months of therapy with fewer side effects, according to results from the IDEA study published in The New England Journal of Medicine.
Adherence to nutrition, physical activity guidelines reduces colon cancer mortality risk
Following American Cancer Society’s exercise, weight and nutrition guidelines appeared associated with a reduced risk for death among patients with colon cancer, study data showed.
Colon cancer survival lower among Medicaid recipients, uninsured
Medicaid recipients or patients who lack health insurance have lower colon cancer survival rates than individuals with private, non-Medicaid insurance, according to new research published in Diseases of the Colon & Rectum.
Smartphone app, algorithm offer insights into symptom burden among chemotherapy-treated patients
Patients with cancer who undergo chemotherapy can be monitored remotely with smartphone sensors and an algorithm that detects worsening symptoms based upon objective changes in patient behavior, according to results of a pilot study.
FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a proposed trastuzumab biosimilar, issuing Complete Response Letters for both products.
Cyramza improves OS, PFS for hepatocellular carcinoma
The phase 3 REACH-2 trial of ramucirumab met its primary endpoint of OS and its secondary endpoint of PFS for the second-line treatment of patients with hepatocellular carcinoma with high alpha-fetoprotein, according to the agent’s manufacturer.
Distal colon cancer risk lower among women who avoid red meat
Women who avoided eating red meat showed a lower risk for distal colon cancer, but not other types of colorectal cancer, in a new study published in the International Journal of Cancer.
Multidisciplinary care benefits patients with rectal cancer
Patients with rectal cancer could benefit if medical institutions implement multidisciplinary team approaches to managing their disease, according to two studies published in the Journal of the American College of Surgeons.
-
Headline News
‘Unethical’ conversion therapy tied to ‘poor mental health’
October 01, 20242 min read -
Headline News
Mental health counseling more effective at reducing preterm birth vs. antidepressants
October 01, 20242 min read -
Headline News
Discharge setting following sepsis hospitalization linked to readmission
October 03, 20242 min read
-
Headline News
‘Unethical’ conversion therapy tied to ‘poor mental health’
October 01, 20242 min read -
Headline News
Mental health counseling more effective at reducing preterm birth vs. antidepressants
October 01, 20242 min read -
Headline News
Discharge setting following sepsis hospitalization linked to readmission
October 03, 20242 min read